Global Pomalidomide Market Growth 2025-2031
The global Pomalidomide market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Pomalidomide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pomalidomide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pomalidomide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pomalidomide players cover Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Pomalidomide Industry Forecast” looks at past sales and reviews total world Pomalidomide sales in 2024, providing a comprehensive analysis by region and market sector of projected Pomalidomide sales for 2025 through 2031. With Pomalidomide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pomalidomide industry.
This Insight Report provides a comprehensive analysis of the global Pomalidomide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pomalidomide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pomalidomide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pomalidomide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pomalidomide.
This report presents a comprehensive overview, market shares, and growth opportunities of Pomalidomide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pomalidomide market?
What factors are driving Pomalidomide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pomalidomide market opportunities vary by end market size?
How does Pomalidomide break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Pomalidomide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pomalidomide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pomalidomide is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pomalidomide players cover Celgene, Natco Pharma, Intas Pharmaceuticals, Indiabulls Pharmaceutical, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Pomalidomide Industry Forecast” looks at past sales and reviews total world Pomalidomide sales in 2024, providing a comprehensive analysis by region and market sector of projected Pomalidomide sales for 2025 through 2031. With Pomalidomide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pomalidomide industry.
This Insight Report provides a comprehensive analysis of the global Pomalidomide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pomalidomide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pomalidomide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pomalidomide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pomalidomide.
This report presents a comprehensive overview, market shares, and growth opportunities of Pomalidomide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1mg Tables
- 2mg Tables
- 4mg Tables
- Hospital
- Drug Center
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Celgene
- Natco Pharma
- Intas Pharmaceuticals
- Indiabulls Pharmaceutical
- Cipla
- Glenmark Pharmaceuticals
- Dr Reddy's Laboratories
- Qilu Pharmaceutical
- Chia Tai-Tianqing
- Hanson Pharm
- Meidakang Huakang Pharmaceutical
- Shandong Kongfu Pharmaceutical
- SL PHARM
What is the 10-year outlook for the global Pomalidomide market?
What factors are driving Pomalidomide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pomalidomide market opportunities vary by end market size?
How does Pomalidomide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pomalidomide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pomalidomide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pomalidomide by Country/Region, 2020, 2024 & 2031
2.2 Pomalidomide Segment by Type
2.2.1 1mg Tables
2.2.2 2mg Tables
2.2.3 4mg Tables
2.3 Pomalidomide Sales by Type
2.3.1 Global Pomalidomide Sales Market Share by Type (2020-2025)
2.3.2 Global Pomalidomide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pomalidomide Sale Price by Type (2020-2025)
2.4 Pomalidomide Segment by Application
2.4.1 Hospital
2.4.2 Drug Center
2.4.3 Clinic
2.4.4 Others
2.5 Pomalidomide Sales by Application
2.5.1 Global Pomalidomide Sale Market Share by Application (2020-2025)
2.5.2 Global Pomalidomide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pomalidomide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pomalidomide Breakdown Data by Company
3.1.1 Global Pomalidomide Annual Sales by Company (2020-2025)
3.1.2 Global Pomalidomide Sales Market Share by Company (2020-2025)
3.2 Global Pomalidomide Annual Revenue by Company (2020-2025)
3.2.1 Global Pomalidomide Revenue by Company (2020-2025)
3.2.2 Global Pomalidomide Revenue Market Share by Company (2020-2025)
3.3 Global Pomalidomide Sale Price by Company
3.4 Key Manufacturers Pomalidomide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pomalidomide Product Location Distribution
3.4.2 Players Pomalidomide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POMALIDOMIDE BY GEOGRAPHIC REGION
4.1 World Historic Pomalidomide Market Size by Geographic Region (2020-2025)
4.1.1 Global Pomalidomide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pomalidomide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pomalidomide Market Size by Country/Region (2020-2025)
4.2.1 Global Pomalidomide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pomalidomide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pomalidomide Sales Growth
4.4 APAC Pomalidomide Sales Growth
4.5 Europe Pomalidomide Sales Growth
4.6 Middle East & Africa Pomalidomide Sales Growth
5 AMERICAS
5.1 Americas Pomalidomide Sales by Country
5.1.1 Americas Pomalidomide Sales by Country (2020-2025)
5.1.2 Americas Pomalidomide Revenue by Country (2020-2025)
5.2 Americas Pomalidomide Sales by Type (2020-2025)
5.3 Americas Pomalidomide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pomalidomide Sales by Region
6.1.1 APAC Pomalidomide Sales by Region (2020-2025)
6.1.2 APAC Pomalidomide Revenue by Region (2020-2025)
6.2 APAC Pomalidomide Sales by Type (2020-2025)
6.3 APAC Pomalidomide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pomalidomide by Country
7.1.1 Europe Pomalidomide Sales by Country (2020-2025)
7.1.2 Europe Pomalidomide Revenue by Country (2020-2025)
7.2 Europe Pomalidomide Sales by Type (2020-2025)
7.3 Europe Pomalidomide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pomalidomide by Country
8.1.1 Middle East & Africa Pomalidomide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pomalidomide Revenue by Country (2020-2025)
8.2 Middle East & Africa Pomalidomide Sales by Type (2020-2025)
8.3 Middle East & Africa Pomalidomide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pomalidomide
10.3 Manufacturing Process Analysis of Pomalidomide
10.4 Industry Chain Structure of Pomalidomide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pomalidomide Distributors
11.3 Pomalidomide Customer
12 WORLD FORECAST REVIEW FOR POMALIDOMIDE BY GEOGRAPHIC REGION
12.1 Global Pomalidomide Market Size Forecast by Region
12.1.1 Global Pomalidomide Forecast by Region (2026-2031)
12.1.2 Global Pomalidomide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pomalidomide Forecast by Type (2026-2031)
12.7 Global Pomalidomide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Celgene
13.1.1 Celgene Company Information
13.1.2 Celgene Pomalidomide Product Portfolios and Specifications
13.1.3 Celgene Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Celgene Main Business Overview
13.1.5 Celgene Latest Developments
13.2 Natco Pharma
13.2.1 Natco Pharma Company Information
13.2.2 Natco Pharma Pomalidomide Product Portfolios and Specifications
13.2.3 Natco Pharma Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Natco Pharma Main Business Overview
13.2.5 Natco Pharma Latest Developments
13.3 Intas Pharmaceuticals
13.3.1 Intas Pharmaceuticals Company Information
13.3.2 Intas Pharmaceuticals Pomalidomide Product Portfolios and Specifications
13.3.3 Intas Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Intas Pharmaceuticals Main Business Overview
13.3.5 Intas Pharmaceuticals Latest Developments
13.4 Indiabulls Pharmaceutical
13.4.1 Indiabulls Pharmaceutical Company Information
13.4.2 Indiabulls Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Indiabulls Pharmaceutical Main Business Overview
13.4.5 Indiabulls Pharmaceutical Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Pomalidomide Product Portfolios and Specifications
13.5.3 Cipla Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Glenmark Pharmaceuticals
13.6.1 Glenmark Pharmaceuticals Company Information
13.6.2 Glenmark Pharmaceuticals Pomalidomide Product Portfolios and Specifications
13.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Glenmark Pharmaceuticals Main Business Overview
13.6.5 Glenmark Pharmaceuticals Latest Developments
13.7 Dr Reddy's Laboratories
13.7.1 Dr Reddy's Laboratories Company Information
13.7.2 Dr Reddy's Laboratories Pomalidomide Product Portfolios and Specifications
13.7.3 Dr Reddy's Laboratories Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dr Reddy's Laboratories Main Business Overview
13.7.5 Dr Reddy's Laboratories Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Chia Tai-Tianqing
13.9.1 Chia Tai-Tianqing Company Information
13.9.2 Chia Tai-Tianqing Pomalidomide Product Portfolios and Specifications
13.9.3 Chia Tai-Tianqing Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Chia Tai-Tianqing Main Business Overview
13.9.5 Chia Tai-Tianqing Latest Developments
13.10 Hanson Pharm
13.10.1 Hanson Pharm Company Information
13.10.2 Hanson Pharm Pomalidomide Product Portfolios and Specifications
13.10.3 Hanson Pharm Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Hanson Pharm Main Business Overview
13.10.5 Hanson Pharm Latest Developments
13.11 Meidakang Huakang Pharmaceutical
13.11.1 Meidakang Huakang Pharmaceutical Company Information
13.11.2 Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Meidakang Huakang Pharmaceutical Main Business Overview
13.11.5 Meidakang Huakang Pharmaceutical Latest Developments
13.12 Shandong Kongfu Pharmaceutical
13.12.1 Shandong Kongfu Pharmaceutical Company Information
13.12.2 Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shandong Kongfu Pharmaceutical Main Business Overview
13.12.5 Shandong Kongfu Pharmaceutical Latest Developments
13.13 SL PHARM
13.13.1 SL PHARM Company Information
13.13.2 SL PHARM Pomalidomide Product Portfolios and Specifications
13.13.3 SL PHARM Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 SL PHARM Main Business Overview
13.13.5 SL PHARM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pomalidomide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pomalidomide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pomalidomide by Country/Region, 2020, 2024 & 2031
2.2 Pomalidomide Segment by Type
2.2.1 1mg Tables
2.2.2 2mg Tables
2.2.3 4mg Tables
2.3 Pomalidomide Sales by Type
2.3.1 Global Pomalidomide Sales Market Share by Type (2020-2025)
2.3.2 Global Pomalidomide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pomalidomide Sale Price by Type (2020-2025)
2.4 Pomalidomide Segment by Application
2.4.1 Hospital
2.4.2 Drug Center
2.4.3 Clinic
2.4.4 Others
2.5 Pomalidomide Sales by Application
2.5.1 Global Pomalidomide Sale Market Share by Application (2020-2025)
2.5.2 Global Pomalidomide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pomalidomide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pomalidomide Breakdown Data by Company
3.1.1 Global Pomalidomide Annual Sales by Company (2020-2025)
3.1.2 Global Pomalidomide Sales Market Share by Company (2020-2025)
3.2 Global Pomalidomide Annual Revenue by Company (2020-2025)
3.2.1 Global Pomalidomide Revenue by Company (2020-2025)
3.2.2 Global Pomalidomide Revenue Market Share by Company (2020-2025)
3.3 Global Pomalidomide Sale Price by Company
3.4 Key Manufacturers Pomalidomide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pomalidomide Product Location Distribution
3.4.2 Players Pomalidomide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POMALIDOMIDE BY GEOGRAPHIC REGION
4.1 World Historic Pomalidomide Market Size by Geographic Region (2020-2025)
4.1.1 Global Pomalidomide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pomalidomide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pomalidomide Market Size by Country/Region (2020-2025)
4.2.1 Global Pomalidomide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pomalidomide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pomalidomide Sales Growth
4.4 APAC Pomalidomide Sales Growth
4.5 Europe Pomalidomide Sales Growth
4.6 Middle East & Africa Pomalidomide Sales Growth
5 AMERICAS
5.1 Americas Pomalidomide Sales by Country
5.1.1 Americas Pomalidomide Sales by Country (2020-2025)
5.1.2 Americas Pomalidomide Revenue by Country (2020-2025)
5.2 Americas Pomalidomide Sales by Type (2020-2025)
5.3 Americas Pomalidomide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pomalidomide Sales by Region
6.1.1 APAC Pomalidomide Sales by Region (2020-2025)
6.1.2 APAC Pomalidomide Revenue by Region (2020-2025)
6.2 APAC Pomalidomide Sales by Type (2020-2025)
6.3 APAC Pomalidomide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pomalidomide by Country
7.1.1 Europe Pomalidomide Sales by Country (2020-2025)
7.1.2 Europe Pomalidomide Revenue by Country (2020-2025)
7.2 Europe Pomalidomide Sales by Type (2020-2025)
7.3 Europe Pomalidomide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pomalidomide by Country
8.1.1 Middle East & Africa Pomalidomide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pomalidomide Revenue by Country (2020-2025)
8.2 Middle East & Africa Pomalidomide Sales by Type (2020-2025)
8.3 Middle East & Africa Pomalidomide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pomalidomide
10.3 Manufacturing Process Analysis of Pomalidomide
10.4 Industry Chain Structure of Pomalidomide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pomalidomide Distributors
11.3 Pomalidomide Customer
12 WORLD FORECAST REVIEW FOR POMALIDOMIDE BY GEOGRAPHIC REGION
12.1 Global Pomalidomide Market Size Forecast by Region
12.1.1 Global Pomalidomide Forecast by Region (2026-2031)
12.1.2 Global Pomalidomide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pomalidomide Forecast by Type (2026-2031)
12.7 Global Pomalidomide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Celgene
13.1.1 Celgene Company Information
13.1.2 Celgene Pomalidomide Product Portfolios and Specifications
13.1.3 Celgene Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Celgene Main Business Overview
13.1.5 Celgene Latest Developments
13.2 Natco Pharma
13.2.1 Natco Pharma Company Information
13.2.2 Natco Pharma Pomalidomide Product Portfolios and Specifications
13.2.3 Natco Pharma Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Natco Pharma Main Business Overview
13.2.5 Natco Pharma Latest Developments
13.3 Intas Pharmaceuticals
13.3.1 Intas Pharmaceuticals Company Information
13.3.2 Intas Pharmaceuticals Pomalidomide Product Portfolios and Specifications
13.3.3 Intas Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Intas Pharmaceuticals Main Business Overview
13.3.5 Intas Pharmaceuticals Latest Developments
13.4 Indiabulls Pharmaceutical
13.4.1 Indiabulls Pharmaceutical Company Information
13.4.2 Indiabulls Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.4.3 Indiabulls Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Indiabulls Pharmaceutical Main Business Overview
13.4.5 Indiabulls Pharmaceutical Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Pomalidomide Product Portfolios and Specifications
13.5.3 Cipla Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Glenmark Pharmaceuticals
13.6.1 Glenmark Pharmaceuticals Company Information
13.6.2 Glenmark Pharmaceuticals Pomalidomide Product Portfolios and Specifications
13.6.3 Glenmark Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Glenmark Pharmaceuticals Main Business Overview
13.6.5 Glenmark Pharmaceuticals Latest Developments
13.7 Dr Reddy's Laboratories
13.7.1 Dr Reddy's Laboratories Company Information
13.7.2 Dr Reddy's Laboratories Pomalidomide Product Portfolios and Specifications
13.7.3 Dr Reddy's Laboratories Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dr Reddy's Laboratories Main Business Overview
13.7.5 Dr Reddy's Laboratories Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.8.3 Qilu Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Chia Tai-Tianqing
13.9.1 Chia Tai-Tianqing Company Information
13.9.2 Chia Tai-Tianqing Pomalidomide Product Portfolios and Specifications
13.9.3 Chia Tai-Tianqing Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Chia Tai-Tianqing Main Business Overview
13.9.5 Chia Tai-Tianqing Latest Developments
13.10 Hanson Pharm
13.10.1 Hanson Pharm Company Information
13.10.2 Hanson Pharm Pomalidomide Product Portfolios and Specifications
13.10.3 Hanson Pharm Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Hanson Pharm Main Business Overview
13.10.5 Hanson Pharm Latest Developments
13.11 Meidakang Huakang Pharmaceutical
13.11.1 Meidakang Huakang Pharmaceutical Company Information
13.11.2 Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Meidakang Huakang Pharmaceutical Main Business Overview
13.11.5 Meidakang Huakang Pharmaceutical Latest Developments
13.12 Shandong Kongfu Pharmaceutical
13.12.1 Shandong Kongfu Pharmaceutical Company Information
13.12.2 Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolios and Specifications
13.12.3 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Shandong Kongfu Pharmaceutical Main Business Overview
13.12.5 Shandong Kongfu Pharmaceutical Latest Developments
13.13 SL PHARM
13.13.1 SL PHARM Company Information
13.13.2 SL PHARM Pomalidomide Product Portfolios and Specifications
13.13.3 SL PHARM Pomalidomide Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 SL PHARM Main Business Overview
13.13.5 SL PHARM Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pomalidomide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pomalidomide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 1mgTables
Table 4. Major Players of 2mgTables
Table 5. Major Players of 4mgTables
Table 6. Global Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Pomalidomide Sales Market Share by Type (2020-2025)
Table 8. Global Pomalidomide Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pomalidomide Revenue Market Share by Type (2020-2025)
Table 10. Global Pomalidomide Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Pomalidomide Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Pomalidomide Sale Market Share by Application (2020-2025)
Table 13. Global Pomalidomide Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pomalidomide Revenue Market Share by Application (2020-2025)
Table 15. Global Pomalidomide Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Pomalidomide Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Pomalidomide Sales Market Share by Company (2020-2025)
Table 18. Global Pomalidomide Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pomalidomide Revenue Market Share by Company (2020-2025)
Table 20. Global Pomalidomide Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Pomalidomide Producing Area Distribution and Sales Area
Table 22. Players Pomalidomide Products Offered
Table 23. Pomalidomide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pomalidomide Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Pomalidomide Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pomalidomide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pomalidomide Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pomalidomide Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Pomalidomide Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pomalidomide Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pomalidomide Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pomalidomide Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Pomalidomide Sales Market Share by Country (2020-2025)
Table 36. Americas Pomalidomide Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Pomalidomide Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Pomalidomide Sales Market Share by Region (2020-2025)
Table 41. APAC Pomalidomide Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Pomalidomide Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Pomalidomide Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Pomalidomide Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Pomalidomide Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Pomalidomide
Table 53. Key Market Challenges & Risks of Pomalidomide
Table 54. Key Industry Trends of Pomalidomide
Table 55. Pomalidomide Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pomalidomide Distributors List
Table 58. Pomalidomide Customer List
Table 59. Global Pomalidomide Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Pomalidomide Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pomalidomide Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Pomalidomide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pomalidomide Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Pomalidomide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pomalidomide Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Pomalidomide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pomalidomide Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Pomalidomide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pomalidomide Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Pomalidomide Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pomalidomide Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Pomalidomide Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Celgene Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 74. Celgene Pomalidomide Product Portfolios and Specifications
Table 75. Celgene Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Celgene Main Business
Table 77. Celgene Latest Developments
Table 78. Natco Pharma Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 79. Natco Pharma Pomalidomide Product Portfolios and Specifications
Table 80. Natco Pharma Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Natco Pharma Main Business
Table 82. Natco Pharma Latest Developments
Table 83. Intas Pharmaceuticals Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 84. Intas Pharmaceuticals Pomalidomide Product Portfolios and Specifications
Table 85. Intas Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Intas Pharmaceuticals Main Business
Table 87. Intas Pharmaceuticals Latest Developments
Table 88. Indiabulls Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 89. Indiabulls Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 90. Indiabulls Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Indiabulls Pharmaceutical Main Business
Table 92. Indiabulls Pharmaceutical Latest Developments
Table 93. Cipla Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 94. Cipla Pomalidomide Product Portfolios and Specifications
Table 95. Cipla Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments
Table 98. Glenmark Pharmaceuticals Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 99. Glenmark Pharmaceuticals Pomalidomide Product Portfolios and Specifications
Table 100. Glenmark Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Glenmark Pharmaceuticals Main Business
Table 102. Glenmark Pharmaceuticals Latest Developments
Table 103. Dr Reddy's Laboratories Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 104. Dr Reddy's Laboratories Pomalidomide Product Portfolios and Specifications
Table 105. Dr Reddy's Laboratories Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Dr Reddy's Laboratories Main Business
Table 107. Dr Reddy's Laboratories Latest Developments
Table 108. Qilu Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 109. Qilu Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 110. Qilu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Qilu Pharmaceutical Main Business
Table 112. Qilu Pharmaceutical Latest Developments
Table 113. Chia Tai-Tianqing Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 114. Chia Tai-Tianqing Pomalidomide Product Portfolios and Specifications
Table 115. Chia Tai-Tianqing Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. Chia Tai-Tianqing Main Business
Table 117. Chia Tai-Tianqing Latest Developments
Table 118. Hanson Pharm Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 119. Hanson Pharm Pomalidomide Product Portfolios and Specifications
Table 120. Hanson Pharm Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. Hanson Pharm Main Business
Table 122. Hanson Pharm Latest Developments
Table 123. Meidakang Huakang Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 124. Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 125. Meidakang Huakang Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Meidakang Huakang Pharmaceutical Main Business
Table 127. Meidakang Huakang Pharmaceutical Latest Developments
Table 128. Shandong Kongfu Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 129. Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 130. Shandong Kongfu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Shandong Kongfu Pharmaceutical Main Business
Table 132. Shandong Kongfu Pharmaceutical Latest Developments
Table 133. SL PHARM Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 134. SL PHARM Pomalidomide Product Portfolios and Specifications
Table 135. SL PHARM Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. SL PHARM Main Business
Table 137. SL PHARM Latest Developments
Table 1. Pomalidomide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pomalidomide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 1mgTables
Table 4. Major Players of 2mgTables
Table 5. Major Players of 4mgTables
Table 6. Global Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Pomalidomide Sales Market Share by Type (2020-2025)
Table 8. Global Pomalidomide Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pomalidomide Revenue Market Share by Type (2020-2025)
Table 10. Global Pomalidomide Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Pomalidomide Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Pomalidomide Sale Market Share by Application (2020-2025)
Table 13. Global Pomalidomide Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pomalidomide Revenue Market Share by Application (2020-2025)
Table 15. Global Pomalidomide Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Pomalidomide Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Pomalidomide Sales Market Share by Company (2020-2025)
Table 18. Global Pomalidomide Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pomalidomide Revenue Market Share by Company (2020-2025)
Table 20. Global Pomalidomide Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Pomalidomide Producing Area Distribution and Sales Area
Table 22. Players Pomalidomide Products Offered
Table 23. Pomalidomide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pomalidomide Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Pomalidomide Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pomalidomide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pomalidomide Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pomalidomide Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Pomalidomide Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pomalidomide Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pomalidomide Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pomalidomide Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Pomalidomide Sales Market Share by Country (2020-2025)
Table 36. Americas Pomalidomide Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Pomalidomide Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Pomalidomide Sales Market Share by Region (2020-2025)
Table 41. APAC Pomalidomide Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Pomalidomide Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Pomalidomide Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Pomalidomide Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Pomalidomide Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pomalidomide Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Pomalidomide Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Pomalidomide
Table 53. Key Market Challenges & Risks of Pomalidomide
Table 54. Key Industry Trends of Pomalidomide
Table 55. Pomalidomide Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pomalidomide Distributors List
Table 58. Pomalidomide Customer List
Table 59. Global Pomalidomide Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Pomalidomide Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pomalidomide Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Pomalidomide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pomalidomide Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Pomalidomide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pomalidomide Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Pomalidomide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pomalidomide Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Pomalidomide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pomalidomide Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Pomalidomide Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pomalidomide Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Pomalidomide Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Celgene Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 74. Celgene Pomalidomide Product Portfolios and Specifications
Table 75. Celgene Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Celgene Main Business
Table 77. Celgene Latest Developments
Table 78. Natco Pharma Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 79. Natco Pharma Pomalidomide Product Portfolios and Specifications
Table 80. Natco Pharma Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Natco Pharma Main Business
Table 82. Natco Pharma Latest Developments
Table 83. Intas Pharmaceuticals Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 84. Intas Pharmaceuticals Pomalidomide Product Portfolios and Specifications
Table 85. Intas Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Intas Pharmaceuticals Main Business
Table 87. Intas Pharmaceuticals Latest Developments
Table 88. Indiabulls Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 89. Indiabulls Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 90. Indiabulls Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Indiabulls Pharmaceutical Main Business
Table 92. Indiabulls Pharmaceutical Latest Developments
Table 93. Cipla Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 94. Cipla Pomalidomide Product Portfolios and Specifications
Table 95. Cipla Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments
Table 98. Glenmark Pharmaceuticals Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 99. Glenmark Pharmaceuticals Pomalidomide Product Portfolios and Specifications
Table 100. Glenmark Pharmaceuticals Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Glenmark Pharmaceuticals Main Business
Table 102. Glenmark Pharmaceuticals Latest Developments
Table 103. Dr Reddy's Laboratories Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 104. Dr Reddy's Laboratories Pomalidomide Product Portfolios and Specifications
Table 105. Dr Reddy's Laboratories Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Dr Reddy's Laboratories Main Business
Table 107. Dr Reddy's Laboratories Latest Developments
Table 108. Qilu Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 109. Qilu Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 110. Qilu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Qilu Pharmaceutical Main Business
Table 112. Qilu Pharmaceutical Latest Developments
Table 113. Chia Tai-Tianqing Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 114. Chia Tai-Tianqing Pomalidomide Product Portfolios and Specifications
Table 115. Chia Tai-Tianqing Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. Chia Tai-Tianqing Main Business
Table 117. Chia Tai-Tianqing Latest Developments
Table 118. Hanson Pharm Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 119. Hanson Pharm Pomalidomide Product Portfolios and Specifications
Table 120. Hanson Pharm Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. Hanson Pharm Main Business
Table 122. Hanson Pharm Latest Developments
Table 123. Meidakang Huakang Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 124. Meidakang Huakang Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 125. Meidakang Huakang Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. Meidakang Huakang Pharmaceutical Main Business
Table 127. Meidakang Huakang Pharmaceutical Latest Developments
Table 128. Shandong Kongfu Pharmaceutical Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 129. Shandong Kongfu Pharmaceutical Pomalidomide Product Portfolios and Specifications
Table 130. Shandong Kongfu Pharmaceutical Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Shandong Kongfu Pharmaceutical Main Business
Table 132. Shandong Kongfu Pharmaceutical Latest Developments
Table 133. SL PHARM Basic Information, Pomalidomide Manufacturing Base, Sales Area and Its Competitors
Table 134. SL PHARM Pomalidomide Product Portfolios and Specifications
Table 135. SL PHARM Pomalidomide Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. SL PHARM Main Business
Table 137. SL PHARM Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pomalidomide
Figure 2. Pomalidomide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pomalidomide Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Pomalidomide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pomalidomide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pomalidomide Sales Market Share by Country/Region (2024)
Figure 10. Pomalidomide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 1mgTables
Figure 12. Product Picture of 2mgTables
Figure 13. Product Picture of 4mgTables
Figure 14. Global Pomalidomide Sales Market Share by Type in 2025
Figure 15. Global Pomalidomide Revenue Market Share by Type (2020-2025)
Figure 16. Pomalidomide Consumed in Hospital
Figure 17. Global Pomalidomide Market: Hospital (2020-2025) & (K Pcs)
Figure 18. Pomalidomide Consumed in Drug Center
Figure 19. Global Pomalidomide Market: Drug Center (2020-2025) & (K Pcs)
Figure 20. Pomalidomide Consumed in Clinic
Figure 21. Global Pomalidomide Market: Clinic (2020-2025) & (K Pcs)
Figure 22. Pomalidomide Consumed in Others
Figure 23. Global Pomalidomide Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Pomalidomide Sale Market Share by Application (2024)
Figure 25. Global Pomalidomide Revenue Market Share by Application in 2025
Figure 26. Pomalidomide Sales by Company in 2025 (K Pcs)
Figure 27. Global Pomalidomide Sales Market Share by Company in 2025
Figure 28. Pomalidomide Revenue by Company in 2025 ($ millions)
Figure 29. Global Pomalidomide Revenue Market Share by Company in 2025
Figure 30. Global Pomalidomide Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Pomalidomide Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Pomalidomide Sales 2020-2025 (K Pcs)
Figure 33. Americas Pomalidomide Revenue 2020-2025 ($ millions)
Figure 34. APAC Pomalidomide Sales 2020-2025 (K Pcs)
Figure 35. APAC Pomalidomide Revenue 2020-2025 ($ millions)
Figure 36. Europe Pomalidomide Sales 2020-2025 (K Pcs)
Figure 37. Europe Pomalidomide Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Pomalidomide Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Pomalidomide Revenue 2020-2025 ($ millions)
Figure 40. Americas Pomalidomide Sales Market Share by Country in 2025
Figure 41. Americas Pomalidomide Revenue Market Share by Country (2020-2025)
Figure 42. Americas Pomalidomide Sales Market Share by Type (2020-2025)
Figure 43. Americas Pomalidomide Sales Market Share by Application (2020-2025)
Figure 44. United States Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Pomalidomide Sales Market Share by Region in 2025
Figure 49. APAC Pomalidomide Revenue Market Share by Region (2020-2025)
Figure 50. APAC Pomalidomide Sales Market Share by Type (2020-2025)
Figure 51. APAC Pomalidomide Sales Market Share by Application (2020-2025)
Figure 52. China Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 56. India Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Pomalidomide Sales Market Share by Country in 2025
Figure 60. Europe Pomalidomide Revenue Market Share by Country (2020-2025)
Figure 61. Europe Pomalidomide Sales Market Share by Type (2020-2025)
Figure 62. Europe Pomalidomide Sales Market Share by Application (2020-2025)
Figure 63. Germany Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 64. France Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Pomalidomide Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Pomalidomide Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Pomalidomide Sales Market Share by Application (2020-2025)
Figure 71. Egypt Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pomalidomide in 2025
Figure 77. Manufacturing Process Analysis of Pomalidomide
Figure 78. Industry Chain Structure of Pomalidomide
Figure 79. Channels of Distribution
Figure 80. Global Pomalidomide Sales Market Forecast by Region (2026-2031)
Figure 81. Global Pomalidomide Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Pomalidomide Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Pomalidomide Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Pomalidomide Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Pomalidomide Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Pomalidomide
Figure 2. Pomalidomide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pomalidomide Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Pomalidomide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pomalidomide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pomalidomide Sales Market Share by Country/Region (2024)
Figure 10. Pomalidomide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 1mgTables
Figure 12. Product Picture of 2mgTables
Figure 13. Product Picture of 4mgTables
Figure 14. Global Pomalidomide Sales Market Share by Type in 2025
Figure 15. Global Pomalidomide Revenue Market Share by Type (2020-2025)
Figure 16. Pomalidomide Consumed in Hospital
Figure 17. Global Pomalidomide Market: Hospital (2020-2025) & (K Pcs)
Figure 18. Pomalidomide Consumed in Drug Center
Figure 19. Global Pomalidomide Market: Drug Center (2020-2025) & (K Pcs)
Figure 20. Pomalidomide Consumed in Clinic
Figure 21. Global Pomalidomide Market: Clinic (2020-2025) & (K Pcs)
Figure 22. Pomalidomide Consumed in Others
Figure 23. Global Pomalidomide Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Pomalidomide Sale Market Share by Application (2024)
Figure 25. Global Pomalidomide Revenue Market Share by Application in 2025
Figure 26. Pomalidomide Sales by Company in 2025 (K Pcs)
Figure 27. Global Pomalidomide Sales Market Share by Company in 2025
Figure 28. Pomalidomide Revenue by Company in 2025 ($ millions)
Figure 29. Global Pomalidomide Revenue Market Share by Company in 2025
Figure 30. Global Pomalidomide Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Pomalidomide Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Pomalidomide Sales 2020-2025 (K Pcs)
Figure 33. Americas Pomalidomide Revenue 2020-2025 ($ millions)
Figure 34. APAC Pomalidomide Sales 2020-2025 (K Pcs)
Figure 35. APAC Pomalidomide Revenue 2020-2025 ($ millions)
Figure 36. Europe Pomalidomide Sales 2020-2025 (K Pcs)
Figure 37. Europe Pomalidomide Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Pomalidomide Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Pomalidomide Revenue 2020-2025 ($ millions)
Figure 40. Americas Pomalidomide Sales Market Share by Country in 2025
Figure 41. Americas Pomalidomide Revenue Market Share by Country (2020-2025)
Figure 42. Americas Pomalidomide Sales Market Share by Type (2020-2025)
Figure 43. Americas Pomalidomide Sales Market Share by Application (2020-2025)
Figure 44. United States Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Pomalidomide Sales Market Share by Region in 2025
Figure 49. APAC Pomalidomide Revenue Market Share by Region (2020-2025)
Figure 50. APAC Pomalidomide Sales Market Share by Type (2020-2025)
Figure 51. APAC Pomalidomide Sales Market Share by Application (2020-2025)
Figure 52. China Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 56. India Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Pomalidomide Sales Market Share by Country in 2025
Figure 60. Europe Pomalidomide Revenue Market Share by Country (2020-2025)
Figure 61. Europe Pomalidomide Sales Market Share by Type (2020-2025)
Figure 62. Europe Pomalidomide Sales Market Share by Application (2020-2025)
Figure 63. Germany Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 64. France Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Pomalidomide Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Pomalidomide Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Pomalidomide Sales Market Share by Application (2020-2025)
Figure 71. Egypt Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Pomalidomide Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pomalidomide in 2025
Figure 77. Manufacturing Process Analysis of Pomalidomide
Figure 78. Industry Chain Structure of Pomalidomide
Figure 79. Channels of Distribution
Figure 80. Global Pomalidomide Sales Market Forecast by Region (2026-2031)
Figure 81. Global Pomalidomide Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Pomalidomide Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Pomalidomide Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Pomalidomide Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Pomalidomide Revenue Market Share Forecast by Application (2026-2031)